Mark D. King
Impact in
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus
- Tuberculosis Research and Epidemiology
- Infection Control in Healthcare
-
- Antibiotic Use and Resistance
Papers in
-
- Antimicrobial Resistance in Staphylococcus 5
- Tuberculosis Research and Epidemiology 2
-
- Antibiotic Use and Resistance 1
- Co-authors
- Henry M. Blumberg (9 shared papers)Ekaterina V. Kourbatova (5 shared papers)Susan M. Ray (4 shared papers)Yun F. Wang (1 shared paper)Ulrich Seybold (2 shared papers)Jeremiah Gene Johnson (1 shared paper)J. Sue Halvosa (2 shared papers)Fred C. Tenover (1 shared paper)
- Journals
- Clinical Infectious Diseases (5 papers)Annals of Internal Medicine (2 papers)The American Journal of the Medical Sciences (1 paper)International Journal of STD & AIDS (1 paper)American Journal of Infection Control (1 paper)
- Partner nations
- United States
In The Last Decade
Mark D. King
13 papers receiving 2.2k citations
Mark D. King's Hit Papers
Peers
Comparison fields: 5 of 81
- Infectious Diseases 1.6k
- Applied Microbiology and Biotechnology 163
- Molecular Medicine 105
- Pharmacology 49
- Epidemiology 161
Countries citing papers authored by Mark D. King
This map shows the geographic impact of Mark D. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. King more than expected).
Fields of papers citing papers by Mark D. King
This network shows the impact of papers produced by Mark D. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. King. The network helps show where Mark D. King may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D. King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Emergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus USA 300 Clone as the Predominant Cause of Skin and Soft-Tissue Infections Hit paper breakdown → | 2006 | 675 |
| 2 | Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus USA300 Genotype as a Major Cause of Health Care--Associated Blood Stream Infections Hit paper breakdown → | 2006 | 601 |
| 3 | 2005 | 296 | |
| 4 | 2005 | 179 | |
| 5 | 2002 | 170 | |
| 6 | 2002 | 113 | |
| 7 | 2009 | 111 | |
| 8 | 2006 | 74 | |
| 9 | 2002 | 64 | |
| 10 | 2003 | 39 | |
| 11 | 2004 | 21 | |
| 12 | 2004 | 10 | |
| 13 | 2005 | 2 |
About Mark D. King
Mark D. King is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Molecular Medicine, Epidemiology and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 2.4k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (5 papers), Tuberculosis Research and Epidemiology (2 papers), HIV/AIDS oral health manifestations (1 paper), Pneumonia and Respiratory Infections (1 paper), Fungal Infections and Studies (1 paper), Antibiotic Resistance in Bacteria (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper) and Antibiotic Use and Resistance (1 paper). The work is most often cited by research in Infectious Diseases (1.6k citations), Applied Microbiology and Biotechnology (163 citations), Molecular Medicine (105 citations), Pharmacology (49 citations) and Epidemiology (161 citations). Mark D. King has collaborated with scholars based in United States. Frequent co-authors include Henry M. Blumberg, Ekaterina V. Kourbatova, Susan M. Ray, Yun F. Wang, Ulrich Seybold, Jeremiah Gene Johnson, J. Sue Halvosa, Fred C. Tenover, Linda K. McDougal and Alicia Hidrón. Their work appears in journals such as Clinical Infectious Diseases, Annals of Internal Medicine, The American Journal of the Medical Sciences, International Journal of STD & AIDS and American Journal of Infection Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.